Strategic Value Partners and Blantyre Capital Acquire OQ Chemicals

Strategic Value Partners (SVP) and Blantyre Capital Limited (Blantyre) recently announced the acquisition of OQ Chemicals (Oxea), a leading global producer and merchant of oxo chemicals.

Strategic Value Partners and Blantyre Capital acquired OQ Chemicals,...
Strategic Value Partners and Blantyre Capital acquired OQ Chemicals, reinstating its name to Oxea and reaffirming its heritage in the global chemicals industry. © Oxea

As part of the acquisition, OQ Chemicals will reinstate its name to Oxea, reaffirming its heritage and longstanding presence in the global chemicals industry.

Oxea is a leading manufacturer of oxo intermediates and performance chemicals, providing essential ingredients to specialty chemicals and additive manufacturers in key US and European markets. The company produces high-quality alcohols, polyols, plasticizers, carboxylic acids, specialty esters, and amines, crucial for paints, coatings, plastics, lubricants, pharmaceuticals, and other sectors. Oxea supports global supply chains and long-term demand in high-growth industries like construction, automotive, and electronics. Oxea markets its chemicals in more than 60 countries, with primary production sites in Germany and Texas, ensuring a strong global presence.

“Oxea’s leading market positions, global reach, and innovation capabilities provide a solid foundation for long-term growth,” said HJ Woltery, Co-Head of the European Investment Team at SVP. “We look forward to partnering with the Oxea team to build upon this strong foundation and continue delivering exceptional value to its customers and stakeholders across well-diversified markets.”

“We are pleased to partner with Oxea, a market leader with strong production capabilities,” said Mubashir Mukadam, Chief Investment Officer at Blantyre Capital. “Oxea’s significant expertise in oxo chemicals, combined with its global footprint, presents ample opportunities for growth. We look forward to supporting the Company as it continues to expand its product offerings and enhance its strategic position in the industry.”

SVP and Blantyre were advised on the transaction by Kirkland & Ellis, Akin, and Lazard.

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read